Poso A - Search Results

1

The Universal 3D QSAR Model for Dopamine D₂ Receptor Antagonists.

Zięba A, Żuk J, Bartuzi D, Matosiuk D, Poso A, Kaczor AA. Zięba A, et al. Among authors: poso a. Int J Mol Sci. 2019 Sep 14;20(18):4555. doi: 10.3390/ijms20184555. Int J Mol Sci. 2019. PMID: 31540025 Free PMC article.

2

A structure-activity relationship study of catechol-O-methyltransferase inhibitors combining molecular docking and 3D QSAR methods.

Tervo AJ, Nyrönen TH, Rönkkö T, Poso A. Tervo AJ, et al. Among authors: poso a. J Comput Aided Mol Des. 2003 Dec;17(12):797-810. doi: 10.1023/b:jcam.0000021831.47952.a7. J Comput Aided Mol Des. 2003. PMID: 15124929

3

Comparing the quality and predictiveness between 3D QSAR models obtained from manual and automated alignment.

Tervo AJ, Nyrönen TH, Rönkkö T, Poso A. Tervo AJ, et al. Among authors: poso a. J Chem Inf Comput Sci. 2004 May-Jun;44(3):807-16. doi: 10.1021/ci0342268. J Chem Inf Comput Sci. 2004. PMID: 15154745

4

3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data.

Salo OM, Savinainen JR, Parkkari T, Nevalainen T, Lahtela-Kakkonen M, Gynther J, Laitinen JT, Järvinen T, Poso A. Salo OM, et al. Among authors: poso a. J Med Chem. 2006 Jan 26;49(2):554-66. doi: 10.1021/jm0505157. J Med Chem. 2006. PMID: 16420041

5

3-Heterocycle-phenyl N-alkylcarbamates as FAAH inhibitors: design, synthesis and 3D-QSAR studies.

Käsnänen H, Myllymäki MJ, Minkkilä A, Kataja AO, Saario SM, Nevalainen T, Koskinen AM, Poso A. Käsnänen H, et al. Among authors: poso a. ChemMedChem. 2010 Feb 1;5(2):213-31. doi: 10.1002/cmdc.200900390. ChemMedChem. 2010. PMID: 20024981

6

Studying the catechol binding cavity in comparative models of human dopamine D2 receptor.

Sakhteman A, Lahtela-Kakkonen M, Poso A. Sakhteman A, et al. Among authors: poso a. J Mol Graph Model. 2011 Feb;29(5):685-92. doi: 10.1016/j.jmgm.2010.11.012. Epub 2010 Dec 2. J Mol Graph Model. 2011. PMID: 21168353

7

Chiral 1,3,4-oxadiazol-2-ones as highly selective FAAH inhibitors.

Patel JZ, Parkkari T, Laitinen T, Kaczor AA, Saario SM, Savinainen JR, Navia-Paldanius D, Cipriano M, Leppänen J, Koshevoy IO, Poso A, Fowler CJ, Laitinen JT, Nevalainen T. Patel JZ, et al. Among authors: poso a. J Med Chem. 2013 Nov 14;56(21):8484-96. doi: 10.1021/jm400923s. Epub 2013 Oct 22. J Med Chem. 2013. PMID: 24083878

8

Structure-based molecular modeling approaches to GPCR oligomerization.

Kaczor AA, Selent J, Poso A. Kaczor AA, et al. Among authors: poso a. Methods Cell Biol. 2013;117:91-104. doi: 10.1016/B978-0-12-408143-7.00005-0. Methods Cell Biol. 2013. PMID: 24143973

9

Structural studies, homology modeling and molecular docking of novel non-competitive antagonists of GluK1/GluK2 receptors.

Kaczor AA, Karczmarzyk Z, Fruziński A, Pihlaja K, Sinkkonen J, Wiinämaki K, Kronbach C, Unverferth K, Poso A, Matosiuk D. Kaczor AA, et al. Among authors: poso a. Bioorg Med Chem. 2014 Jan 15;22(2):787-95. doi: 10.1016/j.bmc.2013.12.013. Epub 2013 Dec 12. Bioorg Med Chem. 2014. PMID: 24368028

10

Quantitative insights for the design of substrate-based SIRT1 inhibitors.

Kokkonen P, Mellini P, Nyrhilä O, Rahnasto-Rilla M, Suuronen T, Kiviranta P, Huhtiniemi T, Poso A, Jarho E, Lahtela-Kakkonen M. Kokkonen P, et al. Among authors: poso a. Eur J Pharm Sci. 2014 Aug 1;59:12-9. doi: 10.1016/j.ejps.2014.04.003. Epub 2014 Apr 18. Eur J Pharm Sci. 2014. PMID: 24747578

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

297 results

Search Page